These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 23226521)

  • 21. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.
    Halawani D; LeBlanc AC; Rouiller I; Michnick SW; Servant MJ; Latterich M
    Mol Cell Biol; 2009 Aug; 29(16):4484-94. PubMed ID: 19506019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
    Costantini S; Capone F; Polo A; Bagnara P; Budillon A
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational changes of p97 during nucleotide hydrolysis determined by small-angle X-Ray scattering.
    Davies JM; Tsuruta H; May AP; Weis WI
    Structure; 2005 Feb; 13(2):183-95. PubMed ID: 15698563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities.
    Wang Q; Song C; Li CC
    Biochem Biophys Res Commun; 2003 Jan; 300(2):253-60. PubMed ID: 12504076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways.
    Meyer HH; Shorter JG; Seemann J; Pappin D; Warren G
    EMBO J; 2000 May; 19(10):2181-92. PubMed ID: 10811609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
    Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
    Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
    Liu S; Fu QS; Zhao J; Hu HY
    Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATP-binding sites in brain p97/VCP (valosin-containing protein), a multifunctional AAA ATPase.
    Zalk R; Shoshan-Barmatz V
    Biochem J; 2003 Sep; 374(Pt 2):473-80. PubMed ID: 12747802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47.
    Dreveny I; Kondo H; Uchiyama K; Shaw A; Zhang X; Freemont PS
    EMBO J; 2004 Mar; 23(5):1030-9. PubMed ID: 14988733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational changes in the AAA ATPase p97-p47 adaptor complex.
    Beuron F; Dreveny I; Yuan X; Pye VE; McKeown C; Briggs LC; Cliff MJ; Kaneko Y; Wallis R; Isaacson RL; Ladbury JE; Matthews SJ; Kondo H; Zhang X; Freemont PS
    EMBO J; 2006 May; 25(9):1967-76. PubMed ID: 16601695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating p97 Inhibitor Analogues for Potency against p97-p37 and p97-Npl4-Ufd1 Complexes.
    Gui L; Zhang X; Li K; Frankowski KJ; Li S; Wong DE; Moen DR; Porubsky PR; Lin HJ; Schoenen FJ; Chou TF
    ChemMedChem; 2016 May; 11(9):953-7. PubMed ID: 27043824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Dynamic molecular basis for malfunction in disease mutants of p97/VCP.
    Schuetz AK; Kay LE
    Elife; 2016 Nov; 5():. PubMed ID: 27828775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multisystem Proteinopathy Mutations in VCP/p97 Increase NPLOC4·UFD1L Binding and Substrate Processing.
    Blythe EE; Gates SN; Deshaies RJ; Martin A
    Structure; 2019 Dec; 27(12):1820-1829.e4. PubMed ID: 31623962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detailed structural insights into the p97-Npl4-Ufd1 interface.
    Isaacson RL; Pye VE; Simpson P; Meyer HH; Zhang X; Freemont PS; Matthews S
    J Biol Chem; 2007 Jul; 282(29):21361-9. PubMed ID: 17491009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The structural and functional basis of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually exclusive binding of cofactors to the N-terminal domain of p97.
    Hänzelmann P; Schindelin H
    J Biol Chem; 2011 Nov; 286(44):38679-38690. PubMed ID: 21914798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between the AAA
    Rao MV; Williams DR; Cocklin S; Loll PJ
    J Biol Chem; 2017 Nov; 292(45):18392-18407. PubMed ID: 28939772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the D1-D2 Linker of Human VCP/p97 in the Asymmetry and ATPase Activity of the D1-domain.
    Tang WK; Xia D
    Sci Rep; 2016 Jan; 6():20037. PubMed ID: 26818443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleotide dependent motion and mechanism of action of p97/VCP.
    DeLaBarre B; Brunger AT
    J Mol Biol; 2005 Mar; 347(2):437-52. PubMed ID: 15740751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into adaptor binding to the AAA protein p97.
    Yeung HO; Kloppsteck P; Niwa H; Isaacson RL; Matthews S; Zhang X; Freemont PS
    Biochem Soc Trans; 2008 Feb; 36(Pt 1):62-7. PubMed ID: 18208387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding into new markets--VCP/p97 in endocytosis and autophagy.
    Bug M; Meyer H
    J Struct Biol; 2012 Aug; 179(2):78-82. PubMed ID: 22450227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.